We understand the importance of intellectual property for our clients, and we appreciate having the opportunity to present at this year’s meeting
West Lafayette, Ind. (PRWEB)
March 21, 2023
Improved Pharma will be at the ACS Spring 2023 National Meeting to be held in Indianapolis March 26 – 30, 2023. There are two opportunities to interact with Improved Pharma at this event.
On Monday March 27th is the reception is for the Chemistry and Law Division of ACS, whose purpose is to advance the understanding and application of the intersection between chemistry and relevant statutory, regulatory, and judicial framework. Improved Pharma is pleased to be a sponsor for this event. The reception takes place from 6:00 – 8:00 PM in room 239 at the Indiana Convention Center and is open to all attendees of the national meeting.
On March 28th, Pamela Smith, Vice President and COO of Improved Pharma will be presenting “Microspectroscopy in art conservation and archaeology: Early applications from the MML” in the Science in Support of Technical Art History session. Her presentation takes place at 8:05 AM in room 122 at the Indiana Convention Center. Dr. Smith’s invited presentation opens the special session for the Division of the History of Chemistry. She will discuss how infrared, Raman, and visible microspectroscopy were used to identify pigments, dyes, binders, fibers, and other organic components in various paintings, fabrics, and manuscripts.
“We are pleased to be able to contribute to the ACS Spring 2023 National meeting, where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge”, remarked Sally Byrn, CEO of Improved Pharma. “We understand the importance of intellectual property for our clients, and we appreciate having the opportunity to present at this year’s meeting.”
About Improved Pharma
Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.
For more information about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.
Share article on social media or email: